NIH

Latest

A health official holds Lenacapavir, a long‑acting HIV prevention treatment, in Epworth outside the capital Harare, Zimbabwe, February 19, 2026.REUTERS/Philimon Bulawayo
Poverty

Lenacapavir: the HIV Breakthrough Proving Why NIH Funding Matters

Biomedical advances such as lenacapavir depend on years of publicly funded basic research

A customer waits for his medicine in a pharmacy, in downtown Cairo, Egypt, on November 17, 2016.
Governance

Holding Drug Companies Accountable: NIH Access Plan vs. Pandemic Treaty

Four enforcement mechanisms the policy frameworks could consider to promote drug affordability